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1. Introduction 
The iron-storage protein, ferritin, is capable of 
accumulating up to 4500 Fe atoms. Iron enters the 
large cavity inside the protein through inter-subunit 
channels [l] and is deposited as microcrystalline 
hydrous ferric oxide [2]. Reconstitution can be 
achieved by adding Fe(I1) to apoferritin in the 
presence of an oxidant. The protein acts as a catalyst 
and successfully competes with Fe(H)-oxidation 
outside the protein shell [3-61. 
Alternative mechanisms of iron accumulations 
have been discussed [4--71. The main point of 
difference between them is whether the catalytic 
action of the protein is confined to the initial stages 
of oxidation and the provision of nucleation centres, 
on which further iron can be deposited directly, or 
whether there are active sites on the protein at which 
all Fe(I1) entering the molecule is oxidised. Such 
catalytic centres have been proposed [8] to contain a 
pair of Fe(U) atoms, which co-operatively reduce O2 
to peroxide. This seems to suggest a requirement for 
O2 as oxidant. The ‘nucleation’ model was preferred 
[4]. In their kinetic studies an excess of the oxidising 
systemKI03/NazS~O~ wasused rather than 02 alone, 
so that rate-limiting effects of O2 depletion could be 
avoided. O2 was not excluded from the solutions 
used, although the amount present was usually well 
under that required to account for the Fe(II)-oxidized. 
We now compare the effectiveness of KI03/Na2S203 
in the absence of O2 with that of O2 alone. We find 
that oxidation is more rapid with O2 at the initial 
stages of Fe(II)-oxidation, but, when some iron is 
already present in the molecule, the two oxidants are 
equally effective. 
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2. Materials and methods 
Horse spleen ferritin was isolated from tissue 
homogenates by heat treatment followed by high 
speed centrifugation [9] and further purified by gel 
filtration on Sepharose 6B. Apoferritin was prepared 
from ferritin by reduction with thioglycollic acid 
[lo]. Chemicals used were AnalaR grade. 
Ferritin fractions containing a small amount of 
iron were obtained from ferritin reconstituted to an 
average Fe content of 750 Fe atoms/molecule. The 
reconstitution procedure used was that in [lo]. After 
concentration, fractionation of the reconstituted 
ferritin solution was carried out in an MSE Superspeed 
50 centrifuge (10 X 10 ml rotor) according to 
scheme 1. After each centrifugation step the super- 
natant was divided into fractions by careful with- 
drawal of solution from the top of the centrifuge 
tube with a syringe. 
Fe(I1) solutions were prepared by adding solid 
Fe(II)(NH4),(S04)2.6 Hz0 to distilled Hz0 through 
which Nz had been bubbled for at least. 1 h. Solutions 
were kept stoppered at 4’C. Fe-uptake into apoferritin 
or ferritin solutions in 20 mM Hepes-NaOH 
(N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic 
acid) buffer, was monitored in a recording 
spectrophotometer by use of the increasing A420 due 
to the production of red-brown ferric micelles. The 
procedure for Fe-uptake in the absence of O2 was as 
follows: Deaerated buffer, with or without 2 mM 
KI03/8 mM NaZS203 was placed in a cuvette and 
Silicone DC antifoam MS A compound (Hopkin and 
Williams, Chadwell Heath, Essex) was layered on top. 
Air was excluded with a suba seal and 02.free N2 
[ 1 I] was bubbled through the buffer for 30 min. 
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Scheme I 
Reconstituted Eerritin 
(av.750 Fe atoms/molecule) 
70-250 Fe atoms/molecule dissalved in Hz0 
, 
S3_xpernatant fractions 
240-800 Fe atoms/molecule 
Procedure used for fractionation of reconsSituted ferritin cantaiaiag an average nf 750 Fe atoms/molecute 
Protein was then added wi% a syringe to give a mn- 
centration af 1 n&ml (2.2 PM) and bubbling of& 
continued for a further IS min. The cuvette was 
placed in the spectrophotometer (Unicam SP18QQ) 
and the Fe(D) solution added with a microsyringee 
The controt sample con~ajn~n~ no oxidanf was also 
covered with a layer of sificune antifoam, but Nz 
bubbling was omitted. 
3. ResuIts 
Figure 1 shows the time course of fhe ox~~a~I~~ 
by apoferritirz of 1.5 mM l?e(Il)(NH,),(SO& in the 
It can be seen that the initial rate af oxidation is 
faster in the absence of added KIOs/Na&C& but 
that when the O2 in solution (about 0.25 1.1mol f13f) 
has aII been used up the reaction stops. At this stag 
about 1 FmoI out of the I .5 pmol Fe@) present has 
been oxidized, or about 4 Fe(II)/Q2 molecule. 
Oxidation continues when further small amounts of 
O2 are admitted (arrows) and again proceeds until 
02 is depleted. Althou& the initial rate is slower in 
the presence of the oxidizing s+em, it continues 
until all the Fe(D) has been oxidized and does not 
stop when O2 has been depleted. The reactions 
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Fig.1, Progress curves of Fe(U)-uptake by apoferritin. Reac- 
tions were started by addition of Fe(II)(NH,),(SO,), (to 
1.5 mM) to apoferritin (0.5 mg/ml) in 0.02 M Hepes, NaOH 
buffer (pH 7.4) and followed by recording the increase in 
A,,, . Curve (a) atmospheric 0, the only oxidant, arrows 
indicate remixing; curve (b) oxidation in the presence of 
3 mM KIOJ12 mM Na,S,O,. 
shown in fig.1 were carried out at pH 7.4, the pH 
used in [4], although the buffer used in the present 
study was different (Hepes rather than imidazole). At 
lower pH values (6.2-7.2) the difference in the initial 
rates with and without the oxidizing system is even 
more pronounced and again the curves cross. 
These results show that even when dissolved O2 has 
been used up, oxidation proceeds, the oxidizing 
equivalents being provided by the KI03/Na2S203 
system. 
The relative effectiveness of the oxidizing system 
in the initial and secondary stages of Fe(H)-oxidation 
(by apoferritin and a ferritin fraction containing 
500 Fe atoms/molecule) are shown in fig.2, which 
also demonstrates the relative effectiveness of KI03 
and O2 as oxidants in the initial stages. The control 
shows little Fe(U)-oxidation in the presence of apo- 
ferritin under anaerobic conditions in the absence 
of KI03. However, when KI03/Na&03 is added 
anaerobically oxidation does proceed, although 
slowly. When air is admitted to the control, oxidation 
occurs much more rapidly than with KI03/Na&0a 
alone. However, when the apoferritin is replaced by 
a ferritin fraction containing a small Fe(III)-hydrous 
oxide nucleus (about 500 Fe atoms/molecule), 
oxidation is just as fast with the oxidizing system and 
20 40 
Time (min.). 
Fig.2. Progress curves of Fe(H)-uptake by ferritin and apo- 
ferritin. Reactions were started by addition of Fe(II)(NH,), 
(SO,), (to 0.2 mM) to ferritin or apoferritin (1 mg/ml 
protein), giving 90 Fe atoms/molecule added, and followed 
by recording the increase in A,,,. AF, no oxidant: apo- 
ferritin without 0, or KIO,/Na,S,O,, the arrow indicates 
opening of the cuvette to air. AF, KIO,: apoferritin plus 
2 mM KIOJ8 mM Na,S,O,, oxygen excluded. AF, 0,: 
apoferritin control open to air. F, KIO,: ferritin fractions 
containing 515 Fe atoms/molecule plus 2 mM KI0,/8 mM 
Na,S,O,, oxygen excluded. 
no 02, as with apoferritin and oxygen alone (fig.2). 
4. Discussion 
The results described above indicate that O2 is not 
a specific substrate for the oxidation of Fe(I1) by 
apoferritin or ferritin. The mechanism proposed 
[8] involving specific binding sites for O2 between 
2 bound Fe(I1) atoms is therefore not only unneces- 
sary, but can certainly be excluded, where oxidation 
occurs in the absence of OZ. 
These lend further support to the two-stage 
oxidation mechanism [4]. Thus O2 appears to be a 
more effective oxidant at the initial stage (nucleation) 
and, indeed, this stage, believed to represent oxidation 
at specific binding sites on the apoferritin shell, is 
actually inhibited by KI03/Na&OJ, whereas at the 
second, ‘crystal growth’ stage, KI03 is just as efficient 
as O2 in promoting the crystal build-up. This strongly 
suggests that oxidation no longer takes place on 
protein sites, but directly on the crystallite surface 
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itself, as proposed [4]. The crystal growth model was 
originally derived from kinetic studies in which the 
oxidizing system was used, and was based on the 
observation that sigmoid progress curves were 
obtained, when relatively large amounts of Fe(H) 
were added (- 500 atoms/molecule). These could be 
broken down into hyperbolic curves of increasing 
initial rates, if the iron was added in successive small 
increments [4]. 
It has been suggested that the sigmoid progress 
curves result from different steps in the same Fe(II)- 
oxidation mechanism becoming rate limiting [ 121. 
However, the results here taken together with those 
in [4,5,13] suggest hat oxidation occurs at 
different sites in the two stages of ferritin formation, 
whether O2 or KIOs/Na$SsOs is used as the oxidant. 
We have shown [ 131 that the ratio of Fe(I1) 
oxidized/Oa molecule varies from 1 S, when a very 
low Fe(I1) concentration, or a very small number of 
Fe(I1) atoms/apoferritin molecule,have been added, to 
4, at a higher Fe(I1) concentration and a larger 
number of Fe(I1) atoms/added protein molecule. The 
greater effectiveness of K10a/Na2S20s in the presence 
of a ferritin fraction, as compared with apoferritin, 
may also result from the greater availability of 
electrons at the many Fe(II)-binding sites on the 
micelle surface. The superiority of O2 over the 
K10s/Na2S20s system at low Fe/apoferritin ratios, 
may be due to its ability to act as a 1 or 2 electron 
acceptor in the absence of sufficient Fe(I1) ions to 
reduce it to water. 
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